You can say that for so very many stocks on the ASX.
Sadly cannot eat or spend potential.
This is certainly a very positive step in the right direction.
I love the technology here, and the products are desperately needed - but I see a massive black hole that needs to be filled with money before they can get this to a stage of delivering a return, either capital or yield.
Still watching and keeping fingers crossed.
GLTA
Cabe
Ann: US FDA Grants Qualified Infectious Disease Product Designati, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
-0.045(10.7%) |
Mkt cap ! $115.6M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 42.0¢ | 37.5¢ | $73.11K | 181.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 200 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 1911 | 2 |
View Market Depth
| Last trade - 15.37pm 29/07/2025 (20 minute delay) ? |
| RCE (ASX) Chart |